Medicare Enrolled

Dr. Deborah Hewitt, APRN

Nurse Practitioner - Family · Crestview, FL
Low-engagement
800 HOSPITAL DR, Crestview, FL 32539
8506821164
In practice since 2008 (18 years)
NPI: 1346412632 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hewitt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hewitt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hewitt

Dr. Deborah Hewitt is a nurse practitioner - family in Crestview, FL, with 18 years in practice.

Between the years covered by Open Payments, Dr. Hewitt received a total of $10,303 from 67 pharmaceutical and/or device companies across 592 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hewitt is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice$ $10,303 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$10,303
Total received (2021-2024)
Avg $2,576/year across 4 years
Top 1% in FL for nurse practitioner - family
67
Companies
592
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,883 (95.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$420 (4.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,006
2023
$3,377
2022
$2,764
2021
$2,156

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,114
Amgen Inc.
$1,029
Janssen Biotech, Inc.
$709
Celgene Corporation
$578
Astellas Pharma US Inc
$494
AstraZeneca Pharmaceuticals LP
$453
Merck Sharp & Dohme LLC
$438
Lilly USA, LLC
$424
E.R. Squibb & Sons, L.L.C.
$343
Takeda Pharmaceuticals U.S.A., Inc.
$339
Eisai Inc.
$241
Daiichi Sankyo Inc.
$238
Octapharma USA, Inc.
$229
Regeneron Healthcare Solutions, Inc.
$228
Exelixis Inc.
$202
GENZYME CORPORATION
$173
Ipsen Biopharmaceuticals, Inc
$154
Stemline Therapeutics Inc.
$153
PFIZER INC.
$136
Genentech USA, Inc.
$129
Deciphera Pharmaceuticals Inc.
$123
SANOFI-AVENTIS U.S. LLC
$121
Seagen Inc.
$120
RECORDATI_RARE_DISEASES_INC.
$116
Alexion Pharmaceuticals, Inc.
$111
EMD Serono, Inc.
$110
PharmaEssentia USA Corporation
$102
Blueprint Medicines Corporation
$101
Coherus Biosciences Inc.
$92
GlaxoSmithKline, LLC.
$90
Myovant Sciences Inc.
$88
ABBVIE INC.
$85
Incyte Corporation
$79
Sumitomo Pharma America, Inc.
$73
Gilead Sciences, Inc.
$72
Merck Sharp & Dohme Corporation
$69
BeiGene USA, Inc.
$63
Heron Therapeutics, Inc.
$60
Rigel Pharmaceuticals, Inc.
$53
TerSera Therapeutics LLC
$50
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
Mirati Therapeutics, Inc.
$43
Karyopharm Therapeutics Inc.
$41
Jazz Pharmaceuticals Inc.
$41
Pharmacosmos Therapeutics Inc.
$38
Spectrum Pharmaceuticals Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$35
SOBI, INC
$35
ARRAY BIOPHARMA INC
$34
Sobi, Inc
$34
JAZZ PHARMACEUTICALS INC.
$34
Foundation Medicine, Inc.
$30
Janssen Scientific Affairs, LLC
$30
AVEO Pharmaceuticals, Inc.
$29
Fennec Pharmaceuticals, Inc.
$26
Alnylam Pharmaceuticals Inc.
$23
ImmunoGen, Inc.
$19
Pharmacyclics LLC, An AbbVie Company
$18
Progenics Pharmaceuticals, Inc.
$17
AbbVie Inc.
$15
Taiho Oncology, Inc.
$15
Verity Pharmaceuticals Inc.
$15
Acceleron Pharma, Inc.
$15
Aveo Pharmaceuticals, Inc.
$14
Acrotech Biopharma Inc.
$14
Kyowa Kirin, Inc.
$14
EUSA Pharma (US) LLC
$12
Top 3 companies account for 27.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELITEK · ENHERTU · EPKINLY · ERLEADA · EVENITY · Elahere · Enhertu · FOTIVDA · FOUNDATIONONE · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · ICLUSIG · IMBRUVICA · IMFINZI · INQOVI · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYLARIFY · Padcev · Pedmark · Pomalyst · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Reblozyl · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SYLVANT · Somatuline Depot · Sylvant · TAFINLAR · TASIGNA · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VPRIV · XALKORI · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in FL.

Looking for a nurse practitioner - family in Crestview?
Compare nurse practitioner - familys in the Crestview area by procedure volume, costs, and industry payment transparency.
Browse nurse practitioner - familys nearby

Geographic Context

Nurse Practitioner - Familys within 10 mi
142
Per 100K population
66.3
County median income
$79,097
Nearest hospital
NORTH OKALOOSA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hewitt is a nurse practitioner - family, and high industry engagement (low-engagement, top 1%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Hewitt receive payments from pharmaceutical companies?
Yes. Dr. Hewitt received a total of $10,303 from 67 companies across 592 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Hewitt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →